AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Imatinib Mesilate Equivalent To Imatinib
10 registrations across 1 African market— 8 active
Markets with Imatinib Mesilate Equivalent To Imatinib
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| NAZZEC 100 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | suspended | Nov 2023 |
| NAZZEC 400 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | suspended | Nov 2023 |
| SUNMATIN 100 | 🇿🇦South Africa | Ranbaxy Pharmaceutical (Pty) Ltd | active | May 2018 |
| IMAVEC | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| GLEEVEC | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| VATIVIO 400 | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| IMATINIB 100 mg ADCO | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | active | Jan 1900 |
| VATIVIO FC | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| IMATINIB 400 mg ADCO | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | active | Jan 1900 |
| GLEEVEC 400 | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
Imatinib Mesilate Equivalent To Imatinib in Africa — Regulatory Overview
Imatinib Mesilate Equivalent To Imatinib is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 10 registrations, 8 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.